Cytokine profiles in bronchoalveolar lavage fluid and blood in HIV-seronegative patients with Pneumocystis carinii pneumonia

European Journal of Clinical Investigation

Volumn 26, Issue 2, 1996, Pages 159-166

  Perenboom, R M ^a   Van Schijndel, A C H W ^a   Beckers, P ^a   Sauerwein, R ^a   Van Hamersvelt, H W ^a   Festen, J ^a   Gallati, H ^b   Van Der Meer, J W M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Interleukin 1; Interleukin 1 receptor antagonist; Interleukin 6; Pneumocystis carinii pneumonia; STNF receptors; TNF

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DISEASE COURSE; HUMAN; LUNG LAVAGE; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL;

EID: 0030038181     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1996.118253.x     Document Type: Article

References (36)

1. Walzer PD. Immunopathogenesis of Pneumocystis carinii infection. J Lab Clin Med 1991;118:206-16.
2. Harmsen AG, Stanckiewicz M. Requirement for CD4+ cells in resistance to Pneumocystis carinii pneumonia in mice. J Exp Med 1990;172:937-45.
3. Shellito J, Suzara VV, Blumenfeld W, Beck JM, Steger HJ, Ermak TH. A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes. J Clin Invest 1990;85:1686-93.
4. Kolls JK, Beck JM, Nelson S, Summer WR, Shellito J. Alveolar macrophage release of tumor necrosis factor during murine Pneumocystis carinii pneumocystis. Am J Respir Cell Mol Biol 1993;8:370-6.
5. Von Behren LA, Pesanti EL. Uptake and degradation of Pneumocystis carinii by macrophages in vitro. Am Rev Respir Dis 1978;118:1051-9.
6. 125I-labelled tumor necrosis factor to Pneumocystis carinii and an insoluble cell wall fraction. J Protozool 1991;38:28S-9S.
7. Donta ST, Pesanti EL. Tumor necrosis factor-a binds to specific receptors on Pneumocystis carinii (abstract) Clin Res 1990;38:352A.
8. Pesanti EL. Interaction of cytokines and alveolar cells with Pneumocystis carinii in vitro J Infect Dis 1991;163:611-16.
9. Chen W, Havell EA, Gigliotti F, Harmsen AG. Interleukin-6 production in a murine model of Pneumocystis carinii pneumonia: relation to resistance and inflammatory response. Infect Immun 1993;61:97-102.
10. Chen W, Havell EA, Moldawer LL, et al. Interleukin-1: An important mediator of host resistance against Pneumocystis carinii. J Exp Med 1992;176:713-18.
11. Chen W, Havell EA, Harmsen AG. Importance of endogenous tumor necrosis factor alpha and gamma interferon in host resistance against Pneumocystis carinii infection. Infect Immun 1992;60:1279-84.
12. Theus SA, Linke MJ, Andrews RP, Walzer PD. Proliferative and cytokine responses to a major surface glycoprotein of Pneumocystis carinii. Infect Immun 1993;61:4703-9.
13. Hoffmans OA, Standing JE, Limper AH. Pneumocystis carinii stimulates tumor necrosis factor-α release from alveolar macrophages through a β-glucan-mediated mechanism. J Immunol 1993;150:3932-40.
14. Tamburrini E, De Luca A, Ventura G et al. Pneumocystis carinii stimulates in vitro production of tumor necrosis factor-α by human macrophages. Med Micribiol Immunol 1991;180:15-20.
15. Krishnan VL, Meager A, Mitchell DM, Pinching AJ, Alveolar macrophages in AIDS patients: increased spontaneous tumour necrosis factor-alpha production in Pneumocystis carinii pneumonia. Clin Exp Immunol 1990;80:156-60.
16. Kandil O, Fisman JA, Koziel H, Pinkston P, Rose RM, Remold HG. Human immunodeficiency virus types 1 infection of human macrophages modulates the cytokine response to Pneumocystis carinii. Infect Immun 1994;62:644-50.
17. Clarke JR, Robinson DS, Coker RJ et al. Role of the human immunodeficiency virus within the lung. Thorax 1995;50:567-76.
18. Churukian CL, Schenk EA. Staining Pneumocystis carinii and fungi in unfixed specimens with ammoniacal silver using a microwave oven. J Histotechnol 1988;11:19-21.
19. Deuren van M, Ven-Jongkrijg van der J, Keuter M, Demacker PNM, Meer van der JWM. Cytokine production in whole blood cultures. J Int Fed Clin Chem 1993;5:216-21.
20. Lisi PJ, Chu CW, Koch GA, Endres S, Lonneman G, Dinarello CA. Development and use of radio immunoassay for human interleukin-1β. Lymphokine Res 1987;6:229-44.
21. Van der Meer JWM, Endres S, Lonneman G et al. Concentrations of immunoreactive human tumor necrosis factor alpha produced by human mononuclear cells in vitro. J Leucoc Biol 1988;43:16-23.
22. Brockhaus M, Bar-Khayim, Gurwicz S, Frensdorf A, Haran N. Plasma levels of tumor necrosis factor soluble receptors in chronic renal failure. Kidney In. 1992;42:663-7.
23. Van Deuren M, van der Ven-Jongekrijg J et al. Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections. J Infect Dis 1994;169:157-61.
24. Keuter M, Dharmana E, Hussein Gasem M et al. Patterns of proinflammatory cytokines and inhibitors during typhoid fever. J Infect Dis 1994;169:1306-11.
25. Simpson SQ, Modi HN, Balk RA, Bone RC, Casey LC. Reduced alveolar macrophage production of tumor necrosis factor during sepsis in mice and men. Crit Care Med 1991;19:1060-6.
26. Luger A, Graf H, Schwarz HP, Stummvoll HK, Luger TA. Decreased serum interleukin 1 activity and monocyte interleukin 1 production in patients with fatal sepsis. Crit Care Med 1986;14:458-61.
27. Kline JN, Monick MM, Hunninghake GW. IL-1 receptor antagonist is regulated differently in human alveolar macrophages than in monocyles. J Appl Physiol 1992;72:1687-92.
28. Moore SA, Stricter RM, Rolfe MW, Standiford TJ, Burdick MD, Kunkel SL. Expression and regulation of human alveolar macrophage-derived interleukin-1 receptor antagonist. Am J Respir Cell Mol Biol 1992;6:569-75.
29. Galve-de Rochemonteix B, Nicod LP et al. Regulation of interleukin-1ra, interleukin-1α, and interleukin-1β production by human alveolar macrophages with phorbol myristate acetate, lipopolysaccharide and interleukin-4. Am J Respir Cell Mol Biol 1993;8:160-8.
30. Vannier E, Miller LC, Dinarello CA. Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleuukin 1 production but upregulates gene expression and synthesis of interleukin 1 receptor antagonist. Proc Natl Acad Sci USA 1992;89:4076-80.
31. Wahl SM, Costa GL, Corcoran M, Wahl LM, Berger AE. Transforming growth factor-β mediates IL-1-dependent induction of IL-1 receptor antagonist. J Immunol 1993;150:3553-60.
32. De Waal Malefijt R, Abrams J, Bennet B, Figdor CG, de Vries JE. Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-20.
33. Shieh JH, Peterson RHF, Moore MAS. Cytokines and dexamethason modulation of IL-1 receptors on human neutrophils in vitro. J Immunol 1993;150:3515-24.
34. Huang ZB, Eden E. Effect of corticosteroids in IL1β and TNFα release by alveolar macrophages from patients with AIDS and Pneumocystis carinii pneumonia. Chest 1993;104:751-55.
35. Peces R, Urra JM, Corostidi M, Lopez-Larrea C. Role of maintenance immunosuppression and methylprednisone in OKT3-induced cytokine release. Transplant Proc 1992;24:2596-9.
36. Santos AS, Scheltinga MR, Lynch E et al. Elaboration of interleukin 1-receptor antagonist is not attenuated by glucocorticoids after endotoxemia. Arch Surg 1993;128:138-44.